Our platform has been launched internationally and is known in many countries by the name meamedica. In France, Germany, Italy, Austria, Switzerland, Belgium, Spain, United Kingdom, United States and Brazil patients can share their experiences with medicines on independent websites. These data are used to perform research with a patient centric focus and an enormous power. Research data are given back to patients in a report.